Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.

Abstract BACKGROUND: The mechanism underlying sorafenib resistance in hepatocellular carcinoma (HCC) remains unclear. Accumulating evidence suggests that tumor-initiating cells (TICs) are a pivotal driving force. Both CD44 and Hedgehog signaling play crucial roles in TIC properties in HCC. In this study, we explored the roles of CD44 and Hedgehog […]

View Original Source at Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.